Merck's KEYNOTE-057 bladder cancer trial ends with results posted; eight more registry updatesNov 13Weekly roundup, 9 itemsDaiichi SankyoMerck & Co., Inc.Updated
Merck registers Phase 2b trial of tulisokibart for noninfectious uveitisOct 9Weekly roundup, 8 itemsglycopyrrolateMerck & Co., Inc.
Merck posts Q2 loss on Terns charge, raises full-year sales outlookAug 4Quarterly updateMerck & Co., Inc.